Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study

被引：0
作者：
Pablo Monedero
Alfredo Gea
Pedro Castro
Angel M. Candela-Toha
María L. Hernández-Sanz
Egoitz Arruti
Jesús Villar
Carlos Ferrando
机构：
[1] Clínica Universidad de Navarra,Department of Anaesthesiology and Intensive Care
[2] University of Navarra,Department of Preventive Medicine and Public Health, Medical School
[3] University of Barcelona,Medical Intensive Care Unit, Hospital Clínic, Institut D’investigació August Pi i Sunyer (IDIBAPS)
[4] Hospital del Ramón y Cajal,Department of Anesthesiology and Critical Care
[5] Hospital de Cruces,Department of Anesthesiology and Critical Care
[6] Ubikare Technology,CIBER de Enfermedades Respiratorias
[7] Instituto de Salud Carlos III,Li Ka Shing Knowledge Institute
[8] St Michael’s Hospital,Multidisciplinary Organ Dysfunction Evaluation Research Network, Research Unit
[9] Hospital Universitario Dr. Negrín,Department of Anesthesiology and Critical Care, Hospital Clínic
[10] Institut D’investigació August Pi i Sunyer,undefined
来源：
Critical Care | / 25卷
关键词：
COVID-19; Intensive Care Unit; Corticosteroids; Critically ill patient; Cohort study; Outcomes; Ventilator-free days; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 65 条
  • [1] Felsenstein S(2020)COVID-19: immunology and treatment options Clin Immunol 215 108448-1316
  • [2] Herbert JA(2020)Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial JAMA 324 1307-629
  • [3] McNamara PS(2020)Corticosteroids in severe COVID-19: a critical view of the evidence Crit Care 24 627-276
  • [4] Hedrich CM(2020)Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial Lancet Respir Med 8 267-625
  • [5] Tomazini BM(2004)A structural approach to selection bias Epidemiology 15 615-1511
  • [6] Maia IS(2020)Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis Leukemia 34 1503-767
  • [7] Cavalcanti AB(2018)Corticosteroid therapy for critically ill patients with middle east respiratory syndrome Am J Respir Crit Care Med 197 757-1720
  • [8] De Backer D(2020)Clinical characteristics of coronavirus disease 2019 in China N Engl J Med 382 1708-475
  • [9] Azoulay E(2020)Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury Lancet 395 473-887
  • [10] Vincent J(2020)Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) Intensive Care Med 46 854-1760
1234567